πΊπΈ Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
πΊπΈ CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ — Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVsβ’), a new category of antivirals engineered to target shared viral mechanisms, today announced that stockholders elected Patricia… Source: prnewswire Country: United States